| Literature DB >> 33344811 |
Anjali Mishra1,2, Yashpal Singh Chhonker1, Amol Chhatrapati Bisen1, Yarra Durga Prasad1, Sachin Laxman Tulsankar1,2, Hardik Chandasana1,2, Tushar Dey3, Sarvesh Kumar Verma1,4, Veenu Bala2,5, Sanjeev Kanojiya6, Sandeep Ghatak3, Rabi Sankar Bhatta1.
Abstract
Antimicrobial agents (Entities:
Year: 2020 PMID: 33344811 PMCID: PMC7745213 DOI: 10.1021/acsomega.0c03863
Source DB: PubMed Journal: ACS Omega ISSN: 2470-1343
Figure 1A representative concatenation of antimicrobial residues in food chain.
Figure 2Representative LC-MS/MS chromatograms of (A) CS blank and (B) analytes in human plasma.
Summary of MS/MS Parameters: Precursor Ion and Fragment Ion Retention Time (RT), Declustering Potential (DP), Collision Energy (CE), and Collision Cell Exit Potential (CXP) for Antimicrobial Drugs
| entry | drug | RT (min) | MRM transitions | DP (V) | CE (eV) | CXP (V) |
|---|---|---|---|---|---|---|
| 1 | ACY | 1.88 | 226.1/152.1 | 64 | 17 | 28 |
| 2 | AMB | 1.37 | 924.6/743.5 | 86 | 127 | 10 |
| 3 | AMP | 1.39 | 350.1/106.1 | 99 | 37 | 10 |
| 4 | ART | 3.33 | 283.1/209.2 | 35 | 16 | 10 |
| 5 | CDR | 1.28 | 365.2/157.9 | 81 | 19 | 10 |
| 6 | CFT | 2.49 | 456.1/396.0 | 85 | 15 | 10 |
| 7 | CEP | 2.14 | 348.1/158.0 | 49 | 15 | 10 |
| 8 | CPD | 1.95 | 558.2/410.1 | 70 | 37 | 10 |
| 9 | CLO | 1.52 | 345.1/277.1 | 26 | 13 | 10 |
| 10 | FLU | 2.04 | 307.1/238.0 | 67 | 23 | 22 |
| 11 | FLX | 1.39 | 310.2/148.0 | 45 | 13 | 10 |
| 12 | GRI | 2.32 | 353.1/165.1 | 85 | 27 | 10 |
| 13 | KET | 1.30 | 531.2/120.1 | 126 | 89 | 10 |
| 14 | NAT | 1.39 | 666.4/503.3 | 76 | 57 | 26 |
| 15 | NFLX | 1.39 | 296.2/134.1 | 44 | 7 | 10 |
| 16 | OFL | 1.29 | 362.1/318.1 | 86 | 27 | 10 |
| 17 | ORN | 2.09 | 220.1/128.1 | 55 | 23 | 10 |
| 18 | PYR | 1.38 | 249.2/198.2 | 95 | 15 | 10 |
| 19 | SDX | 1.99 | 311.1/156.0 | 95 | 24 | 10 |
| 20 | TET | 1.37 | 445.1/410.1 | 51 | 25 | 15 |
Calibrations, QC Range, and Mean Extraction Recoveries and Matrix Effect (P, Plasma; M, Meat)
| mean
extraction recovery (%) | mean
matrix effect (%) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| entry | drug | calibration range (ng/mL) | LLOQ (ng/mL) | LQC (ng/mL) | MQC (ng/mL) | HQC (ng/mL) | P | M | P | M |
| 1 | ACY | 1.56–500 | 1.56 | 3.12 | 100 | 400 | 79 | 72 | 12 | 10 |
| 2 | AMB | 3.12–500 | 3.12 | 6.25 | 100 | 400 | 65 | 57 | 6 | 5 |
| 3 | AMP | 12.5–500 | 12.5 | 20.0 | 100 | 400 | 42 | 50 | 10 | 8 |
| 4 | ART | 0.78–500 | 0.78 | 1.56 | 100 | 400 | 82 | 78 | 8 | 9 |
| 5 | CDR | 0.78–500 | 0.78 | 1.56 | 100 | 400 | 76 | 80 | 3 | 5 |
| 6 | CFT | 1.56–500 | 1.56 | 3.12 | 100 | 400 | 69 | 75 | 9 | 6 |
| 7 | CEP | 3.12–500 | 3.12 | 6.25 | 100 | 400 | 76 | 79 | 8 | 7 |
| 8 | CPD | 3.12–500 | 3.12 | 6.25 | 100 | 400 | 91 | 86 | 7 | 2 |
| 9 | CLO | 0.78–500 | 0.78 | 1.56 | 100 | 400 | 94 | 88 | 8 | 6 |
| 10 | FLU | 0.78–500 | 0.78 | 1.56 | 100 | 400 | 85 | 81 | 9 | 7 |
| 11 | FLX | 0.78–500 | 0.78 | 1.56 | 100 | 400 | 87 | 82 | 6 | 3 |
| 12 | GRI | 0.78–500 | 0.78 | 1.56 | 100 | 400 | 73 | 60 | 13 | 9 |
| 13 | KET | 0.78–500 | 0.78 | 1.56 | 100 | 400 | 89 | 75 | 11 | 7 |
| 14 | NAT | 1.56–500 | 1.56 | 3.12 | 100 | 400 | 69 | 60 | 9 | 4 |
| 15 | NFLX | 0.78–500 | 0.78 | 1.56 | 100 | 400 | 85 | 71 | 4 | 3 |
| 16 | OFL | 3.12–500 | 3.12 | 6.25 | 100 | 400 | 79 | 65 | 6 | 5 |
| 17 | ORN | 0.78–500 | 0.78 | 1.56 | 100 | 400 | 94 | 82 | 4 | 3 |
| 18 | PYR | 0.78–500 | 0.78 | 1.56 | 100 | 400 | 87 | 75 | 6 | 4 |
| 19 | SDX | 0.78–500 | 0.78 | 1.56 | 100 | 400 | 85 | 78 | 8 | 6 |
| 20 | TET | 12.5–500 | 12.5 | 20.0 | 100 | 400 | 63 | 52 | 6 | 2 |
Intraday (a) and Interday (b) Precision and Accuracy Data for Plasmaa
| precision
(% RSD) | accuracy
(% bias) | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LQC | MQC | HQC | LQC | MQC | HQC | ||||||||
| entry | drug | a | |||||||||||
| 1 | ACY | 4.6 | 5.9 | 7.8 | 4.5 | 9.2 | –2.6 | 6.9 | 7.5 | 3.7 | 4.7 | –6.8 | 2.8 |
| 2 | AMB | 8.4 | 7.9 | 3.7 | 4.1 | 6.2 | 3.3 | –7.6 | 2.9 | 4.2 | 11.3 | 4.8 | 2.7 |
| 3 | AMP | 2.6 | 3.9 | 7.2 | 9.5 | 11.3 | 3.5 | 3.7 | 7.8 | 2.7 | 6.8 | 9.7 | 8.5 |
| 4 | ART | 5.7 | 3.6 | 5.6 | 11.6 | 8.7 | 9.4 | –4.6 | 6.7 | –7.8 | 11.3 | –6.5 | 7.9 |
| 5 | CDR | 11.4 | 8.9 | 4.6 | 6.9 | 5.7 | 4.9 | 10.5 | 6.8 | 9.6 | 8.5 | 8.7 | 10.3 |
| 6 | CFT | 2.7 | 5.8 | 10.2 | 7.9 | 11.2 | 5.6 | 7.8 | –6.8 | 3.6 | 10.3 | –2.9 | 13.3 |
| 7 | CEP | 7.8 | 6.9 | 8.9 | 13.5 | 5.8 | 7.9 | 4.8 | 12.8 | 5.9 | 6.8 | 12.7 | 5.7 |
| 8 | CPD | 10.4 | 5.7 | 7.9 | 6.8 | 5.9 | 11.8 | 5.9 | 9.9 | 10.7 | 7.5 | 8.9 | 6.7 |
| 9 | CLO | 8.6 | 5.6 | 4.7 | 5.4 | 11.4 | 7.8 | 10.4 | 12.6 | 4.6 | –3.9 | –8.1 | –7.2 |
| 10 | FLU | 5.9 | 10.4 | 14.6 | 4.7 | 5.8 | 6.3 | –12.6 | 5.7 | –6.8 | 10.4 | –3.8 | 6.9 |
| 11 | FLX | 10.2 | 5.0 | 4.3 | 12.4 | 5.6 | 8.6 | –4.8 | 7.9 | 8.1 | 6.8 | 4.6 | 10.3 |
| 12 | GRI | 5.4 | 3.9 | 11.8 | 7.3 | 10.1 | 4.7 | 8.9 | 3.5 | 6.7 | 9.4 | 5.8 | 2.4 |
| 13 | KET | 4.3 | 12.3 | 4.6 | –8.7 | 12.4 | 10.4 | 5.8 | 8.7 | 9.0 | 5.4 | 9.3 | 11.6 |
| 14 | NAT | 3.8 | 6.9 | 12.5 | 8.9 | 5.8 | 10.4 | 5.9 | –6.5 | 12.5 | 2.8 | 5.7 | –9.1 |
| 15 | NFLX | 8.6 | 7.9 | 8.9 | 10.4 | 5.7 | 10.5 | –9.5 | 5.9 | –10.3 | –7.4 | –13.4 | 10.3 |
| 16 | OFL | 10.9 | 11.4 | 4.6 | 7.8 | 9.8 | 5.6 | 4.3 | –4.6 | 5.6 | 7.5 | 9.8 | 10.2 |
| 17 | ORN | 12.3 | 8.6 | –5.6 | –7.1 | –8.3 | –5.6 | –3.4 | 5.6 | 7.8 | –3.5 | 10.3 | 5.4 |
| 18 | PYR | 10.6 | 5.7 | 14.5 | 8.4 | 10.5 | 6.8 | 10.5 | 9.6 | –8.2 | –7.6 | –7.2 | 8.1 |
| 19 | SDX | 9.1 | 5.8 | 12.5 | 7.3 | 10.8 | 9.3 | –7.6 | 8.7 | 6.8 | –7.4 | –6.9 | 10.9 |
| 20 | TET | 9.2 | 7.4 | 13.3 | 10.4 | 8.6 | 7.6 | 9.8 | 7.9 | 8.1 | 10.8 | 4.6 | –7.3 |
Data are shown as the mean values (n = 5).
Intraday (a) and Interday (b) Precision and Accuracy Data in Meat Matrixa
| precision
(% RSD) | accuracy
(% bias) | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LQC | MQC | HQC | LQC | MQC | HQC | ||||||||
| entry | drug | ||||||||||||
| 1 | ACY | 0.62 | 2.78 | 11.7 | 4.9 | 10.1 | 12.94 | 6.1 | 3.9 | 2.1 | –0.8 | 3.00 | 0.17 |
| 2 | AMB | 7.27 | 10.2 | 4.56 | 10.5 | 2.13 | 11.8 | 1.81 | –9.1 | –0.4 | 2.8 | 3.8 | 1.3 |
| 3 | AMP | 11.9 | 3.3 | 1.9 | 6.53 | 10.5 | 12.8 | 8.7 | 0.96 | 6.1 | 9.9 | 8.6 | 8.8 |
| 4 | ART | 10.9 | 4.6 | 14.3 | 5.32 | 12.8 | 9.8 | 12.3 | 3.8 | 10.6 | –5.6 | 13.1 | 7.6 |
| 5 | CDR | 8.7 | 2.5 | 6.8 | 12.9 | 7.9 | 10.8 | 10.6 | 9.6 | –0.9 | 7.1 | 5.5 | 12.5 |
| 6 | CFT | 10.8 | 4.56 | 13.6 | 3.52 | 8.31 | 2.89 | –7.8 | –1.1 | 8.7 | 8.6 | –3.2 | –5.3 |
| 7 | CEP | 1.76 | 0.83 | 8.72 | 8.73 | 8.71 | 14.45 | 4.8 | 2.8 | –2.6 | 7.7 | 1.2 | 11.6 |
| 8 | CPD | 13.4 | 7.91 | 3.42 | 4.11 | 8.85 | 941 | 9.05 | 8.6 | –5.3 | –10.8 | 1.25 | 7.5 |
| 9 | CLO | 0.92 | 0.75 | 13.2 | 13.3 | 2.98 | 2.58 | –4.4 | –2.4 | –3.8 | –4.53 | –5.7 | –6.8 |
| 10 | FLU | 12.4 | 14.6 | 5.8 | 6.2 | 6.6 | 14.16 | 8.9 | 12.5 | 6.8 | –0.53 | 7.5 | 4.6 |
| 11 | FLX | 10.4 | 10.9 | 8.1 | 9.3 | 8.8 | 10.5 | 12.1 | 11.8 | –0.9 | 1.73 | –5.2 | 0.83 |
| 12 | GRI | 13.3 | 14.6 | 12.9 | 3.5 | 5.04 | 3.8 | 1.52 | 8.4 | 6.8 | –0.53 | 7.3 | 8.0 |
| 13 | KET | 13.3 | 13.6 | 14.8 | 9.70 | 10.26 | 6.45 | 8.7 | –0.9 | 6.1 | 9.8 | 8.6 | 8.8 |
| 14 | NAT | 10.4 | 14.9 | 13.9 | 3.5 | 5.8 | 6.94 | 8.9 | 5.76 | 9.8 | 8.5 | 8.0 | 2.5 |
| 15 | NFLX | 12.1 | 11.6 | 12.8 | 7.7 | 9.26 | 5.45 | 4.3 | 14.6 | –4.4 | 6.4 | 3.87 | –2.8 |
| 16 | OFL | 11.8 | 3.36 | 1.90 | 6.53 | 10.58 | 12.73 | 3.4 | 0.85 | 13.8 | 7.0 | 8.6 | 4.1 |
| 17 | ORN | 13.5 | 13.1 | 4.56 | 5.16 | 1.18 | 2.71 | 3.8 | –0.4 | –5.9 | –10.4 | –7.7 | –8.8 |
| 18 | PYR | 13.5 | 14.1 | 13.9 | 13.5 | 7.9 | 9.26 | 10.2 | 9.2 | 9.6 | –5.8 | –7.1 | 5.5 |
| 19 | SDX | 8.9 | 11.8 | 3.21 | 10.9 | 9.05 | 2.91 | 14.4 | 8.0 | –8.08 | –9.73 | –4.2 | 3.33 |
| 20 | TET | 10.7 | 11.5 | 6.56 | 11.2 | 1.5 | 2.88 | 10.8 | –0.9 | 0.80 | 8.9 | 0.3 | 5.0 |
Data are shown as the mean values (n = 5).
Mean Stability Recoveries of the Antimicrobial Drugs at Different Storage Conditions (P, Plasma; M, Meat)
| mean
stability recoveries (%) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| freeze–thaw (−70 ± 10 °C) | long-term
storage (−70 ± 10 °C, 15 days) | autosampler (4 °C, 24 h) | benchtop (20 ± 5 °C, 24 h) | dry
extract (−20 °C, 24 h) | |||||||
| entry | drug | P | M | P | M | P | M | P | M | P | M |
| 1 | ACY | 98 | 93 | 87 | 88 | 87 | 101 | 98 | 96 | 94 | 99 |
| 2 | AMB | 92 | 91 | 86 | 87 | 94 | 95 | 96 | 94 | 89 | 89 |
| 3 | AMP | 96 | 95 | 90 | 85 | 92 | 98 | 87 | 82 | 91 | 95 |
| 4 | ART | 92 | 96 | 88 | 86 | 102 | 105 | 99 | 90 | 89 | 92 |
| 5 | CDR | 97 | 98 | 89 | 86 | 95 | 98 | 104 | 102 | 93 | 94 |
| 6 | CFT | 91 | 87 | 94 | 93 | 96 | 98 | 97 | 106 | 108 | 110 |
| 7 | CEP | 89 | 88 | 97 | 91 | 86 | 92 | 103 | 110 | 95 | 98 |
| 8 | CPD | 87 | 88 | 88 | 86 | 104 | 95 | 110 | 90 | 93 | 95 |
| 9 | CLO | 89 | 86 | 92 | 90 | 94 | 96 | 86 | 89 | 86 | 86 |
| 10 | FLU | 95 | 90 | 89 | 88 | 95 | 94 | 98 | 84 | 93 | 91 |
| 11 | FLX | 94 | 93 | 94 | 87 | 94 | 90 | 94 | 91 | 94 | 92 |
| 12 | GRI | 87 | 88 | 87 | 88 | 87 | 88 | 87 | 86 | 87 | 88 |
| 13 | KET | 93 | 96 | 98 | 90 | 89 | 89 | 110 | 88 | 91 | 90 |
| 14 | NAT | 86 | 87 | 92 | 94 | 86 | 87 | 95 | 95 | 89 | 91 |
| 15 | NFLX | 96 | 92 | 89 | 88 | 105 | 102 | 95 | 95 | 107 | 100 |
| 16 | OFL | 98 | 92 | 87 | 86 | 94 | 95 | 105 | 102 | 93 | 99 |
| 17 | ORN | 91 | 95 | 95 | 94 | 87 | 98 | 96 | 95 | 87 | 88 |
| 18 | PYR | 95 | 92 | 87 | 88 | 89 | 92 | 91 | 92 | 92 | 95 |
| 19 | SDX | 94 | 91 | 91 | 92 | 86 | 91 | 92 | 93 | 88 | 94 |
| 20 | TET | 94 | 91 | 104 | 95 | 96 | 88 | 108 | 99 | 95 | 95 |
Comparative Evaluation of Clinical Dose, Cmax, LLOQs, and ULOQs of literature data versus experimental data
| reported
literature information | experimental
data | ||||
|---|---|---|---|---|---|
| entry | drug | clinical oral dose | LLOQs–ULOQ (ng/mL) | LLOQs–ULOQ (ng/mL) | |
| 1 | acyclovir[ | 1000 mg/tablet | 4216.5 | 47.6–10 255 | 1.56–400 |
| 2 | amphotericin B[ | 5 mg/kg formulation | 83 000 | 1–2000 | 3.12–400 |
| 3 | ampicillin[ | 500 mg/capsule | 5850 | 100–15 000 | 12.5–400 |
| 4 | artemisinin[ | 500 mg/tablet | 4800 | 1.03–762 | 0.78–400 |
| 5 | cefadroxil[ | 500 mg/tablet | 15 460 | 5–30 000 | 0.78–400 |
| 6 | cefotaxime[ | 1 g/tablet | NA | 100–50 000 | 1.56–400 |
| 7 | cephalexin[ | 250 mg/tablet | 40 000 | 280–16 000 | 3.12–400 |
| 8 | cefpodoxime
proxetil[ | 200 mg/tablet | 2130 | 40–4400 | 3.12–400 |
| 9 | clotrimazole[ | 150 mg/suppository | 0.89 | 0.01563–1.0 | 0.78–400 |
| 10 | fluconazole[ | 12 mg/kg formulation | 15 500 | 10–10 000 | 0.78–400 |
| 11 | fluoxetine[ | 20 mg/tablet | 27 | 0.15–50 | 0.78–400 |
| 12 | griseofulvin[ | 500 mg/ tablet | NA | 20–3000 | 0.78–400 |
| 13 | ketoconazole[ | 200 mg/tablet | 4220 | 2.0–500 | 0.78–400 |
| 14 | natamycin[ | 200 mg/kg formulation | NA | 6.5–400 | 1.56–400 |
| 15 | norfluoxetine[ | 20 mg/tablet | 8.4 | 0.5–50 | 0.78–400 |
| 16 | ofloxacin[ | 200 mg/tablet | NA | 13–2000 | 3.12–400 |
| 17 | ornidazole[ | 1 g/tablet | 16 185 | 100–24 000 | 0.78–400 |
| 18 | pyrimethamine[ | 25 mg/tablet | 598 | 3.12–800 | 0.78–400 |
| 19 | sulfadoxine[ | 500 mg/tablet | 106 000 | 3120–140 000 | 0.78–400 |
| 20 | tetracycline[ | 300 mg/tablet | NA | 50–6000 | 12.5–400 |
Drug Concentration Present per Gram of Tissue (μg/kg)
| sl. no. | sample ID | sample type | acyclovir | amphotericin B | cefpodoxime | clotrimazole | ketoconazole | pyrimethamine |
|---|---|---|---|---|---|---|---|---|
| 1 | M77/15 | pig muscle | 168.5 | |||||
| 2 | M78/15 | pig muscle | 4.945 | 3.96 | ||||
| 3 | M79/15 | beef muscle | ||||||
| 4 | M80/15 | pig intestine | ||||||
| 5 | M81/15 | pig kidney | 2.27 | |||||
| 6 | M83/15 | chicken muscle | 4.915 | 2.185 | ||||
| 7 | M88/15 | pig kidney | 196.5 | 38.15 | ||||
| 8 | M89/15 | pig heart | 35 | |||||
| 9 | M91/15 | chicken muscle | ||||||
| 10 | M92/15 | chicken muscle | ||||||
| 11 | M94/15 | pig muscle | 3.85 | |||||
| 12 | M96/15 | chicken muscle | 9.7 | 3.36 | ||||
| 13 | M97/15 | pig muscle | ||||||
| 14 | M101/15 | beef muscle | 3.185 | |||||
| 15 | M102/15 | pig lung | ||||||
| 16 | M107/15 | chicken muscle | 184 | |||||
| 17 | M111/15 | mutton intestine | ||||||
| 18 | M117/15 | chicken intestine | 3.645 | |||||
| 19 | M131/15 | chicken muscle | ||||||
| 20 | M133/15 | pig muscle | 4.765 | 2.1 | ||||
| 21 | M144/15 | pig muscle | 182.5 | 80.5 | ||||
| 22 | M149/15 | pig muscle | ||||||
| 23 | M159/15 | pig muscle | ||||||
| 24 | M171/15 | chicken muscle | ||||||
| 25 | M176/15 | chicken muscle | 3.28 | 66 | 16.55 | |||
| 26 | M227/15 | chicken muscle | 190.5 |
Drug Concentration Present per Gram of Soil (ng/g)
| levels
of detected antimicrobial agent (ng/g) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| entry | sample ID | ampicillin | cefpodoxime | clotrimazole | norfluoxetine | fluconazole | ketoconazole | ornidazole | tetracyclines |
| 1 | X1(AP) | 2.54 | 0.06 | 0.95 | |||||
| 2 | X2(AP) | ||||||||
| 3 | X3(AP) | ||||||||
| 4 | X4(AP) | 1.70 | 0.76 | 1.7 | |||||
| 5 | X5(AP) | 3.56 | 0.71 | 1.41 | |||||
| 6 | X6(AP) | 0.21 | |||||||
| 7 | L1(AP) | ||||||||
| 8 | L2(AP) | ||||||||
| 9 | L3(AP) | 4.53 | |||||||
| 10 | L4(AP) | ||||||||
| 11 | L5(AP) | ||||||||
| 12 | L6(AP) | ||||||||
| 13 | L7(AP) | ||||||||
| 14 | L8(AP) | ||||||||
| 15 | L1(EP) | ||||||||
| 16 | L1(PF) | 0.42 | 2.78 | ||||||
| 17 | L2(PF) | 0.32 | |||||||
| 18 | L2A(PF) | ||||||||
| 19 | 2L1(PF) | 3.5 | 0.01 | 0.1 | 0.48 | 0.35 | |||
| 20 | 2L2(PF) | 1.43 | 0.02 | 0.39 | 0.28 | ||||
| 21 | 3L1(PF) | ||||||||
| 22 | 4L1(PF) | 0.73 | 1.9 | ||||||
| 23 | 4L2(PF) | 0.03 | 0.30 | 0.79 | |||||
| 24 | P1(DF) | 0.61 | 2.02 | 0.05 | 0.42 | 1.04 | |||
| 25 | P2(DF) | 0.7 | 0.8 | 0.3 | 0.74 | ||||
| 26 | P3(DF) | 4.43 | 0.34 | 0.61 | |||||
| 27 | P4(DF) | 0.82 | 0.43 | 0.41 | |||||
| 28 | P5(DF) | 0.27 | |||||||
| 29 | C1(DF) | ||||||||
Figure 3Illustration representing data from Table , which shows irrational use of above given antimicrobials, among which acyclovir, amphotericin B, and clotrimazole were extensively used and detected above permissible limits in meat samples of multiple vending shops.
Figure 4Illustration representing data from Table , which shows traces of antimicrobial agents in soil samples collected from different locations, among which use of ampicillin, clotrimazole, fluconazole, ketoconazole, and ornidazole was found to be considerably higher.